Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

14%

1 trials in Phase 3/4

Results Transparency

0%

0 of 7 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 2
5(83.3%)
Phase 3
1(16.7%)
6Total
Phase 2(5)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials
NCT03246971Phase 2Completed

Study of Wafermine™ for Post-bunionectomy or Abdominoplasty Pain

Role: lead

NCT02857361Phase 2Completed

Crossover Study to Evaluate the PK Effects of Two Different Wafer Administration Protocols.

Role: lead

NCT02850718Phase 3Completed

A Pivotal Study of the Bioequivalence of Oral Viagra® and a Test Sublingual Sildenafil Wafer

Role: lead

NCT02541396Phase 2Completed

A Study Of The Effectiveness Of Wafermine Alone And In Combination With Opioids In Subjects Undergoing Bunionectomy

Role: lead

NCT02356965Phase 2Completed

Study Testing Ketamine Sublingual Wafer After Wisdom Tooth Extraction

Role: lead

NCT01377831Completed

Study of Ketamine Administered Intravenously and by Sublingual Wafer

Role: lead

NCT02199678Phase 2Completed

A Study to Assess the Analgesic Properties of a Sublingual Wafer Formulation of Ketamine Following Third Molar Extraction

Role: collaborator

All 7 trials loaded